Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glaesserella parasuis (formerly known as Haemophilus parasuis) is a small, pleomorphic, Gram-negative bacterium belonging to the family Pasteurellaceae (Norskov-Lauritsen, 2019). It is a common inhabitant of the upper respiratory tract in swine but can transition into a systemic pathogen causing Glässer's disease, characterized by fibrinous polyserositis, meningitis, and arthritis (Costa-Hurtado et al., 2020). As a whole organism, it is not a single molecular target but rather a pathogen containing multiple potential drug targets such as the cell wall and ribosomes (Nedbalcova et al., 2006). Treatment typically involves the administration of antibiotics like ceftiofur or amoxicillin, which disrupt bacterial structural integrity or metabolic processes (Macedo et al., 2015). Prevention is often managed through vaccination strategies and strict biosecurity measures to limit the impact of virulent strains in pig populations (Dickerman et al., 2020). The bacterium's ability to evade the host immune system through capsule production and biofilm formation complicates treatment and eradication efforts (Costa-Hurtado et al., 2020). Understanding the genetic diversity and serovar distribution of G. parasuis is crucial for developing effective diagnostic tools and cross-protective vaccines (Dickerman et al., 2020).
Antibiotics targeting G. parasuis typically inhibit cell wall synthesis, protein synthesis, or DNA replication.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glaesserella parasuis (G. parasuis).